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Abstract
We describe a method using atomic force microscopy (AFM) to quantify the mechanobiological properties of pluripotent,
stem cell-derived cardiomyocytes, including contraction force, rate, duration, and cellular elasticity. We measured beats
from cardiomyocytes derived from induced pluripotent stem cells of healthy subjects and those with dilated
cardiomyopathy, and from embryonic stem cell lines. We found that our AFM method could quantitate beat forces of
single cells and clusters of cardiomyocytes. We demonstrate the dose-responsive, inotropic effect of norepinephrine and
beta-adrenergic blockade of metoprolol. Cardiomyocytes derived from subjects with dilated cardiomyopathy showed
decreased force and decreased cellular elasticity compared to controls. This AFM-based method can serve as a screening
tool for the development of cardiac-active pharmacological agents, or as a platform for studying cardiomyocyte biology.
Citation: Liu J, Sun N, Bruce MA, Wu JC, Butte MJ (2012) Atomic Force Mechanobiology of Pluripotent Stem Cell-Derived Cardiomyocytes. PLoS ONE 7(5): e37559.
doi:10.1371/journal.pone.0037559
Editor: Daniel J. Muller, Swiss Federal Institute of Technology Zurich, Switzerland
Received December 25, 2011; Accepted April 25, 2012; Published May 18, 2012
Copyright:  2012 Liu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Funding for this work was provided by the National Institutes of Health (NIH) (K08 AI079268) to MJB, NIH New Innovator Award DP2OD004437 and RC1
HL100490 to JCW. This work was partially funded by the Center for Probing the Nanoscale, a National Science Foundation Nanoscale Science and Engineering
Center, supported under Grant No. PHY-0830228 (to MJB). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: manish.butte@stanford.edu
. These authors contributed equally to this work.
Introduction
Diseases of cardiomyocytes, either primary (e.g., genetic
cardiomyopathies) or acquired (e.g., myocardial infarction), are
of major importance to health across the world [1]. Understanding
the physiology and pathophysiology of these vital cells has been the
subject of research for over two centuries. Obtaining human
biopsy specimens from diseased patients, however, requires
expensive and invasive procedures, which may be poorly tolerated
by children or the critically ill. Recent breakthroughs in induced
pluripotent stem cells (iPSC) [2,3] and in genetic engineering of
human embryonic stem cells (hESC) [4] have made human
disease-specific cardiomyocytes available for elucidating mecha-
nisms of specific cardiac diseases. To understand the mechan-
obiology of these stem cell-derived cardiomyocytes, we developed
a method to measure contractile forces, beat frequencies and
durations, and Young’s moduli of live, beating cells.
AFM was first developed to probe nanoscale features of solid
materials using its high sensitivity to intermolecular forces (,pN)
and spatial resolution (,nm). AFM has found applications in
biology to measure features of cells, such as cellular elasticity. AFM
has been used to study CMs in the past [5,6,7], but some of these
efforts required synchronizing the z-piezo of the AFM with beating
of the cardiomyocytes, which created fluidic disturbances that
prevented accurate measurement of contraction forces. Our
method is to touch the cell gently with the AFM cantilever, then
lock the z-piezo, which forces contractions of the cell to deflect the
cantilever. Multiplying the deflection by the spring constant allows
calculation of the contraction force [8].
Results
To obtain beating cardiomyocytes from stem cells, we used
either the hESC line H7 or skin fibroblast-derived iPSCs.
Cardiomyocytes were successfully derived using a well-established
method to differentiate these pluripotent stem cells to the cardiac
lineage [9,10]. These pluripotent stem cell-derived cardiomyocytes
expressed the cardiac markers cardiac troponin T (cTnT),
sarcomeric a-actinin, and myosin light chain 2a (MLC2a) (Fig.
S1), though their spatial organization is more rounded than
rectangular as is seen in CMs obtained from heart tissue.
Moreover, they beat spontaneously in vitro (iPSC-CM in Video
S1 and hESC-CM in Video S2). To measure the force generated
by single CMs, we started by calibrating the spring constant of the
AFM cantilever using the thermal noise method [8]. The typical
spring constant for these cantilevers was around 0.04 N/m. The
cantilever was brought into gentle contact with the surface of a
CM until the cantilever registered a deflection corresponding to
100 pN of force (Fig. 1a), measuring indentation (Fig. 1c).
Thereafter, we turned off feedback to the z-piezo and measured
beats (Fig. 1b). Both iPSC- and hESC-derived cardiomyocytes
contract rhythmically in the axial direction, and we noticed the
force, duration and frequency vary across independent single cells
(Fig. 2a). These stem-cell-derived CMs were grown on gelatin-
coated, glass-bottom petri dishes, and were firmly attached – we
never observed detachment of the cells due to the AFM cantilever.
We found that the iPSC-derived cardiomyocytes (iPSC-CM) beat
comparably to hESC-derived cardiomyocytes (hESC-CM), with
contraction forces of 0.4960.45 nN (n=9) and 0.2360.11 nN
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these cells may be higher than we measured, because there may be
lateral modes of the contraction that are not measured by this
method. These measurements were done at the single point of
each cell that presented the greatest beat force; we assessed the
variation of beat forces at multiple points across single cells later.
The mean beat rate of iPSC-CM was 0.8060.17 beats/s (n=9),
slightly slower than that of hESC-CM at 1.0660.23 beats/s (n=9)
(p=0.015). The mean beat durations were 0.2660.06 s (n=9)
and 0.1960.05 s (n=9) for iPSC-CMs and hESC-CMs, respec-
tively (p=0.075). Our measurements show that the CMs derived
from iPSC and hESC contract with the similar mechanical
properties and support the use of stem cell-derived cardiomyocytes
as a model system.
During culture, the iPSC-CMs can form large clusters
comprising dozens of cells (Fig. 3a) that can be measured by
AFM, as shown in the beat trajectory (Fig. 3b) and in the
histogram of contraction force (Fig. 3c). The beating force of a
single cell within the cluster was 2.3760.16 nN (n=106 beats).
This force was stronger than the force of solitary single cells by an
order of magnitude, at least partly due to the combined movement
of all the cells in the cluster. The beating force of aggregated iPSC-
CMs is regular (force CV=4.8%), in contrast to isolated iPSC
CMs (CV=23%). Additionally, the aggregate contracts with
uniform rhythm: 1.7260.03 beats/s (rate CV=1.7%) as com-
pared to solitary iPSC-CM (CV=20%). The consistency of
contraction force and frequency shows that CMs behave more
synchronously when in contact with other CMs than when
solitary. This result is consistent with the known existence of
cardiac gap junctions, which allow for the spread of action
potentials across CMs. Together, these results show that AFM can
be used to measure solitary CM and the more physiologically
relevant aggregates of CM.
To demonstrate the capability of AFM to measure the effect of
drugs on CMs, we used norepinephrine (NE, 4-[(1R)-2-amino-1-
hydroxyethyl]benzene-1,2-diol), a demethylated form of epineph-
rine that non-specifically activates both alpha-1 and beta-1
adreneregic receptors. NE has long-established effects as both a
positive inotrope, and to lesser extent, a positive chronotrope as
well. To study the effect of NE, we treated both solitary iPSC-CMs
and hESC-CMs with NE at 100 mmol/L concentration and
measured beats before treatment and immediately following
treatment. As shown in the trajectories (Fig. 4a) and statistical
analyses (Fig. 4b), the contraction force of iPSC-CMs increased
significantly from 0.1860.06 nN to 0.4860.23 nN (p,0.001)
upon treatment with NE. The drug also affected the rhythm,
though the chronotropic effect was weaker than the inotropic
effect. After applying NE, 21% of beats were faster than a cutoff of
1.7 beats/s as compared to 6% prior to treatment (Fig. 4b). For the
hESC-CM, the contraction force increased from 0.09760.019 nN
to 0.3160.03 nN (p,0.001) after treatment with NE, but there
was minimal effect on the beat rate.
We next wanted to assess whether AFM could detect the more
subtle effect of dose changes of an inotrope on iPSC-CM. We
treated small clusters of hESC-CM with epinephrine doses from
10 nmol/L to 32 mmol/L and measured beat forces as before. We
found that beat force increased as the dose increased, with an
estimated EC50 of 260 nmol/L (Fig. 4c). This value is in
agreement with previous reports [11]. On average, we found a
2.6-fold increase in force comparing beats prior to treatment with
epinephrine and treatment with 32 mmol/L epinephrine. To test
whether our AFM method could detect inhibition of adrenergic
stimulation, we pre-treated hESC-CM with metoprolol
(100 nmol/L) for 1 hour, then treated the CMs with epinephrine
at sequentially increasing doses from 10 nmol/L to 32 mmol/L.
We saw a slight decrease of beating force upon the first treatment
with epinephrine (10 nmol/L dose), perhaps due to subtle
movement of the tip because of fluidic shifts when the drug was
introduced. Such movements were not seen with subsequent
injections of epinephrine. Importantly, no increases in beat force
was observed upon treatment of epinephrine in the metoprolol-
treated CMs (p=0.17 comparing doses of 10 nM to 32 mM
epinephrine) (Fig. 4d). Together these results show that AFM can
be used to measure both the inotropic and chronotropic effects of
drugs and inhibitors on CMs.
Because the orientation of actin-myosin filaments within a
cardiomyocyte is anisotropic, different parts of the CM show
different amounts of movement and contractile forces with each
beat. To measure the spatial heterogeneity of contraction force, we
developed a method called ‘‘dwell mapping.’’ By superimposing a
grid on the cell, we comprehensively map the cell for elasticity by
nano-indenting at each point on the grid, and for beat properties
by dwelling the cantilever at each point for an interval that enables
the measurement of a few beats. In practice, we sampled grids
comprising 100–1000 points, most of which fell onto the cell and
some of which fell onto the glass surface (Fig. 5a). Because elasticity
and height at the contact point could change during the beat cycle,
these changes could lead to heterogeneity in the measured forces.
Dwell mapping measures the local height and local elasticity
(Young’s modulus) of the cell simultaneously with the local
contraction forces (Fig. 5b,c).
Figure 1. Measurement of force of CMs. (a) The AFM cantilever is
brought into gentle contact with the cardiomyocyte, placing 100 pN of
pre-loaded force on it. The z-piezo is locked and the cantilever tip
dwells on the top of the cardiomyocyte. (b) Shows a typical force
trajectory where the green box shows indentation of the cell. The
contraction of the cardiomyocyte appears as peaks in the trajectory.
The height, full width at half maximum (FWHM) and reciprocal of beat-
to-beat separation of peaks characterize the force, duration and
frequency of cardiomyocyte beat, respectively. The fit of indentation
curve by using Hertz model (red curve in (c)) produces the Young’s
modulus of the cell membrane at the contact point.
doi:10.1371/journal.pone.0037559.g001
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cardiomyopathies [12,13]. Dilated cardiomyopathy (DCM) is a
life-threatening genetic disorder arising from mutations of many
proteins including cardiac troponin T (cTnT) [14,15]. Cardiac
troponin T binds Ca
2+, plays a critical role in the contraction of
CMs, and has been shown to be critical for heart development
[16]. We showed in another work that iPSC-CMs derived from
patients with DCM showed significantly decreased beat forces, but
comparable rates and beat durations as iPSC-CMs derived from
healthy siblings. The patient showed a typical clinical presentation
of DCM [9]. We measured dwell maps of an iPSC-CM derived
from a patient with DCM and found phenotypic differences
compared to a healthy iPSC-CM. The contraction force histogram
and Young’s modulus histogram obtained from dwell maps of the
DCM iPSC-CM show bimodal distributions (Fig. 5d, sides, DCM
in blue). By contrast, the force histogram obtained from dwell
maps of the healthy control iPSC-CM (Fig. 5d, red) shows a single
population of points in terms of beating force and Young’s
modulus. Nonparametric bootstrap analysis of all beating points
on the dwell maps gives a mean force of 1.35 nM for the control
cell (95% confidence interval 1.18 nN–1.54 nN) and 0.55 nN for
the DCM cell (95% CI 0.48 nN–0.64 nN)(Mann-Whitney
p,10
216). Similarly, nonparametric bootstrap analysis of log-
transformed Young’s Moduli showed a mean elasticity of 296 Pa
for the control cell (95% CI 244–367 Pa) and 167 Pa for the DCM
cell (95% CI 116–235 Pa) (Mann-Whitney p=0.0006). To
compare the points of the two dwell maps, we used a two-
dimensional (i.e., Force, Young’s Modulus) Kolmogorov-Smirnov
test and found the DCM and control maps are statistically distinct
(p=3 610
260). These results from dwell-mapping studies show that
iPSC-CM from patients with DCM show increased populations of
points of low elasticity and weak contraction. These results suggest
that mutation of cTnT could both compromise filament structure
and weaken contractile force.
Discussion
The results demonstrate several uses of our AFM method to the
study of cardiomyocytes. By setting the AFM probe to dwell on the
cell, our method quantitatively measures its mechanical pheno-
Figure 2. Single iPSC and hESC cardiomyocytes. Histograms of contraction force, beat width and beat rate of single iPSC-CM (a, top) and hESC-
CM (a, bottom). Each curve in the plot is the smoothed histogram of the beats of a single cell measured at a single site on each cell. (b) Statistical
analysis showing means of individual cells (dots), plus 25
th,5 0
th, and 75
th percentile quantiles (box) and range of all points (whiskers). Statistical
comparison by t test is shown.
doi:10.1371/journal.pone.0037559.g002
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by avoiding fluidic disturbances that hampered previous attempts
to study cardiomyocytes by AFM.
An important problem in the development of new cardiac
agents is to determine whether a compound has inotropic (i.e.,
affecting force generation) or chronotropic (i.e., affecting rate)
effects on the cardiomyocytes. Our AFM-based method quanti-
tates these effects separately, and thus could facilitate pre-clinical
studies of candidate drugs [17]. Because our approach combines
measurement of cellular elasticity, beat force, and rate, it reveals
additional parameters than could be seen by imaging positional
changes of surface beads or by videomicroscopy of the cell edges
[18,19]. This approach could be used to analyze cells from
patients with cardiomyopathy to understand the potential for gene
therapy in these diseases [20]. We used dwell mapping to identify
heterogeneity of the contraction and cellular elasticity of healthy
and diseased iPSC-CMs, providing insight to the underlying
pathophysiology of diseased cardiomyocytes. Overall, our exper-
iments show that AFM can be applied in flexible ways to inform
fundamental, applied, and clinical cardiac studies.
Materials and Methods
Generation and maintenance of pluripotent stem cells
All the protocols for this study were approved by the Stanford
University Human Subjects Research Institutional Review Board.
H7 hESC line was maintained on Matrigel-coated feeder-free
culture dishes with mTESR-1 human pluripotent stem cell
medium (Stemcell Technologies). Generation, maintenance, and
characterization of patient-specific iPSC lines were performed as
previously described [21,22]. Briefly, fibroblasts were grown from
skin biopsies taken from individual subjects and reprogrammed
with lentiviral Yamanaka 4 factors (Oct4, Sox2, Klf4, and c-MYC)
under feeder-free condition. Colonies with TRA-1-60
+ staining
and hESC-like morphology were picked, expanded, and estab-
lished as individual iPSC lines. DCM iPSC lines were confirmed to
contain the specific R173W mutation by genomic PCR and DNA
sequencing. All established iPSC lines expressed the pluripotency
markers Oct4, Nanog, TRA-1-81, and SSEA-4, and were positive
for alkaline phosphatase.
Cardiac lineage specification of pluripotent stem cells
H7 hESCs and iPSCs were differentiated to the CM lineage
using a 3D differentiation protocol modified from Yang [10].
Briefly, embryoid bodies (EBs) were formed in basic media
(StemPro34, Invitrogen, containing 2 mM glutamine, Invitrogen,
0.4 mM monothioglycerol, Sigma, 50 mg/mL ascorbic acid,
Sigma, and 0.5 ng/mL BMP4, R&D Systems) by dissociating
hESCs or iPSCs with Accutase (Sigma) to small clumps containing
10–20 cells on day 0. Cardiac specification of EBs was performed
by adding BMP4 (10 ng/mL), human bFGF (5 ng/mL), and
activin A (3 ng/mL) to the basic media on day 1–4. On day 4–8,
EBs were refreshed with basic media containing human DKK1
(50 ng/mL) and human VEGF (10 ng/mL), followed by basic
media containing human bFGF (5 ng/mL) and human VEGF
(10 ng/mL) starting day 8. All factors were obtained from R&D
Systems. Cultures were maintained in a 5% CO2/air environ-
ment. Spontaneous beating was observed as early as day 8 post
differentiation. Beating EBs were separated by collagenase I into
small beating clusters and single beating CMs for further analyses.
Norepinephrine was obtained from Sigma Aldrich.
Atomic force microscopy (AFM)
iPSC and hESC cardiomyocytes were seeded on a culture dish
with a cover glass bottom (Fluorodish, World Precision Instru-
ments, Inc.). Just before the experiments, the culture media was
changed to Tyrode’s solution (10 mM pH 7.4 HEPES, 140 mM
NaCl, 1.8 mM CaCl2, 5.4 mM KCl, 1 mM MgCl2,1 0 m M
glucose) and maintained at 36uC for the entire experiment. To
Figure 3. AFM measurement of iPSC-CM cluster. (a) Bright field micrograph of cluster of iPSC-CMs. (b) Contraction force trajectory. The
contraction of the CM cluster shows very regular beat force (c), frequency (d) and width (e).
doi:10.1371/journal.pone.0037559.g003
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cantilever deflection, the cantilever was equilibrated in the warm
buffer prior to any experimental measurements until the deflection
was unchanging, for at least 20 minutes. Beating cells were
interrogated by using AFM (MFP-3D Bio, Asylum Research) that
was mounted with a SiNi probe (BudgetSensors). Cells were gently
contacted by the cantilever tip with 100 pN of force (i.e., force
trigger) resulting in a typical cellular indentation of 200–500 nm.
The cantilever tip remained in position with the Z-piezo feedback
off for multiple, sequential, two-minute intervals while deflection
data were collected at an acquisition rate of 2 kHz. Deflection data
were converted to force by multiplying by the spring constant.
We measured cell beats for multiple, sequential intervals that
were usually 1,2 minutes long. Typical noise levels during these
measurements were around 20 pN as shown in the force trajectory
(Fig. 1b). The resulting data were analyzed in Matlab (Math-
Works) to calculate the force, rate, and duration of each beat. To
measure Young’s modulus, as shown in Fig. 1c, we examined the
indentation that occurred prior the deflection of cantilever
reaching the trigger force. We fit the function of force vs.
indentation distance by using the Hertz model, using code in the
Asylum Research software. We used a Poisson’s value of 0.5 for
the cell. The fit produces the Young’s modulus of the cell at the
contact point. We noted some stress relaxation in elasticity
Figure 4. Measurement of drug effect on CMs. (a) Contraction force trajectories measured before and after treatment of iPSC- and hESC-CMs
with norepinephrine. (b) Histograms of contraction force and frequency before and after treatment. (c) Beating force measured from a cluster of iPSC-
CM in response to increasing doses of the adrenergic agonist epinephrine. (d) Beating force measured from a cluster of iPSC-CM in response to
increasing doses of epinephrine, treated prior with the beta-blocker metoprolol.
doi:10.1371/journal.pone.0037559.g004
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etal and other components in response to local indentation – in
this regard, the inverse Young’s moduli reflect ‘‘dynamic
compliance’’ rather than static. The contraction force of each
beat is calculated from the peak value. The beat duration is equal
to the full width at the half maximum (FWHM) and the beat rate is
obtained from the reciprocal of the time interval to the next beat.
For the dwell mapping measurements, the AFM control
program moves the piezo-driving stage to scan an area typically
with 10,30 lines and 10,30 points per line. At each point, the
AFM probe dwells on the cell for 10 s to measure contractions.
From these measurements, the contraction force and cellular
Young’s modulus are calculated. Cell height is measured by the
point of contact for each force curve at each point on the cell. The
precision of the position of AFM tip is in several nanometers.
However, since the cell is highly dynamic, the measured height is
actually a temporal and spatial average of the area around the
AFM tip. Contour plots were calculated automatically using the R
Figure 5. AFM dwell map of dilated cardiomyopathy iPSC-CM. (a) Brightfield image of an iPSC-CM showing the AFM cantilever (black
shadow). The yellow grid superimposed on the cell shows the range of the dwell map. (b) Dwell map showing contraction forces of a single iPSC-CM
at various points on the grid. (c) Dwell map showing Young’s modulus of a single iPSC-CM at various points on the grid. The periphery of the cell had
higher contraction forces and elasticity compared to the central areas. (d) Beating force and Young’s modulus (local elasticity) measurements were
obtained from dwell mapping iPSC-CM derived from either a healthy subject (red) or from a subject with dilated cardiomyopathy (DCM, blue). Single
points on the plot correspond to beat force and elasticity measured at each grid points of the dwell map. Points where no contraction force was
measured (e.g., on the glass slide surrounding the cell) are not shown. The contour plot (middle) represents the probability distribution of dwell
mapped points in the Young’s modulus vs. beating force coordinate system. The contours show that beats measured from most portions of the
healthy iPSC-CM fall in a region of moderate elasticity (50 – 5 kPa) and strong force (,1 nN), whereas some points of the dwell map of DCM iPSC-CM
showed comparatively lower beat forces and lower elasticity. Corresponding histograms that flank the contour plot are the distributions of beat force
(above the contour plot) and elasticity (left of the contour plot), respectively.
doi:10.1371/journal.pone.0037559.g005
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Statistical tests were performed in R or in Matlab. The two-
sample Kolmogorov-Smirnov test compares the distributions of
the values in the two vectors comprising points of Force and
Young’s Moduli for the two samples (DCM and healthy CM). The
null hypothesis is that the two vectors are from the same
continuous distribution. The alternative hypothesis is that they
are from different continuous distributions. The result H is 1 if the
test rejects the null hypothesis at the 5% significance level; 0
otherwise.
Supporting Information
Figure S1 Cardiac markers on CM derived from stem
cells. A. Cardiomyocytes derived from iPSCs expressed cardiac-
specific markers, including sarcomeric a-actinin, cardiac troponin
T (cTnT), and myosin light chain 2a (MLC2a). DAPI fluorescence
imaging shows the nucleus. Scale bars are 50 mm. hESC-CMs
expressed similar cardiac-specific markers (data not shown). B.
Higher resolution images of same markers on iPSC-CM showing
myofibrillar patterns, confirming that a sarcomeric organization
has developed in these cells.
(EPS)
Video S1 Spontaneous beating of cluster of iPSC-CMs.
(WMV)
Video S2 Spontaneous beating of cluster of hESC-CMs.
(WMV)
Author Contributions
Conceived and designed the experiments: MJB MAB JL. Performed the
experiments: MAB JL NS. Analyzed the data: MJB MAB JL. Contributed
reagents/materials/analysis tools: JCW. Wrote the paper: MJB JL.
References
1. Mathers CD, Loncar D (2006) Projections of global mortality and burden of
disease from 2002 to 2030. PLoS Med 3: e442.
2. Yamanaka S (2007) Strategies and new developments in the generation of
patient-specific pluripotent stem cells. Cell Stem Cell 1: 39–49.
3. Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, et al.
(2007) Induced pluripotent stem cell lines derived from human somatic cells.
Science 318: 1917–1920.
4. Hockemeyer D, Jaenisch R (2010) Gene targeting in human pluripotent cells.
Cold Spring Harb Symp Quant Biol 75: 201–209.
5. Domke J, Parak W, George M, Gaub H, Radmacher M (1999) Mapping the
mechanical pulse of single cardiomyocytes with the atomic force microscope.
European Biophysics Journal 28: 179–186.
6. Pelling AE, Veraitch FS, Chu CPK, Nicholls BM, Hemsley AL, et al. (2007)
Mapping correlated membrane pulsations and fluctuations in human cells.
Journal of Molecular Recognition 20: 467–475.
7. Shroff S, Saner D, Lal R (1995) Dynamic micromechanical properties of
cultured rat atrial myocytes measured by atomic force microscopy. American
Journal of Physiology- Cell Physiology 269: C286.
8. Hutter JL, Bechhoefer J (1993) CALIBRATION OF ATOMIC-FORCE
MICROSCOPE TIPS. Review of Scientific Instruments 64: 1868–1873.
9. Sun N, Yazawa M, Liu J, Navarrete EG, Sanchez-Freire V, et al. (2012) Patient-
specific induced pluripotent stem cell as a model for familial dilated
cardiomyopathy. Science Translational Medicine In press.
10. Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008)
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-
cell-derived population. Nature 453: 524–528.
11. Stickle D, Barber R (1989) Evidence for the role of epinephrine binding
frequency in activation of adenylate cyclase. Mol Pharmacol 36: 437–445.
12. Hershberger RE, Cowan J, Morales A, Siegfried JD (2009) Progress with genetic
cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic,
and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart
Fail 2: 253–261.
13. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, et al. (2006)
Contemporary definitions and classification of the cardiomyopathies: an
American Heart Association Scientific Statement from the Council on Clinical
Cardiology, Heart Failure and Transplantation Committee; Quality of Care and
Outcomes Research and Functional Genomics and Translational Biology
Interdisciplinary Working Groups; and Council on Epidemiology and
Prevention. Circulation 113: 1807–1816.
14. Van Acker H, De Sutter J, Vandekerckhove K, de Ravel TJ, Verhaaren H, et al.
(2010) Dilated cardiomyopathy caused by a novel TNNT2 mutation-added
value of genetic testing in the correct identification of affected subjects.
Int J Cardiol 144: 307–309.
15. Wollert KC, Drexler H (2005) Clinical applications of stem cells for the heart.
Circ Res 96: 151–163.
16. Sehnert AJ, Huq A, Weinstein BM, Walker C, Fishman M, et al. (2002) Cardiac
troponin T is essential in sarcomere assembly and cardiac contractility. Nature
Genetics 31: 106–110.
17. Matsa E, Rajamohan D, Dick E, Young L, Mellor I, et al. (2011) Drug
evaluation in cardiomyocytes derived from human induced pluripotent stem
cells carrying a long QT syndrome type 2 mutation. Eur Heart J 32: 952–962.
18. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T (1993) Control of
cardiac muscle cell function by an endogenous nitric oxide signaling system.
Proc Natl Acad Sci U S A 90: 347–351.
19. Sabri A, Alcott SG, Elouardighi H, Pak E, Derian C, et al. (2003) Neutrophil
cathepsin G promotes detachment-induced cardiomyocyte apoptosis via a
protease-activated receptor-independent mechanism. J Biol Chem 278:
23944–23954.
20. Oh Y, Wei H, Ma D, Sun X, Liew R (2012) Clinical applications of patient-
specific induced pluripotent stem cells in cardiovascular medicine. Heart 98:
443–449.
21. Park IH, Lerou PH, Zhao R, Huo H, Daley GQ (2008) Generation of human-
induced pluripotent stem cells. Nat Protoc 3: 1180–1186.
22. Sun N, Panetta NJ, Gupta DM, Wilson KD, Lee A, et al. (2009) Feeder-free
derivation of induced pluripotent stem cells from adult human adipose stem
cells. Proc Natl Acad Sci U S A 106: 15720–15725.
23. Wickham H ggplot2: elegant graphics for data analysis: Springer-Verlag New
York Inc.
Mechanobiology of Stem Cell-Derived Cardiomyocytes
PLoS ONE | www.plosone.org 7 May 2012 | Volume 7 | Issue 5 | e37559